Pediatric and Geriatric Pharmacology Practice Questions

Q: What is the maintenance dose of digoxin in a child, expressed in mg/kg?

0.04-0.06. **Explanation:** The correct maintenance dose of Digoxin in children is **0.04-0.06 mg/kg/day** (Option C). **1. Underlying Medical Concept:** Pediatric dosing for Digoxin is significantly different from adult dosing due to age-related changes in pharmacokinetics. Children, particularly infants (beyond the neonatal period), require higher doses per kilogram of body weight compared to adults. This is attributed to: * **Larger Volume of Distribution ($V_d$):** Children have a higher percentage of total body water and different tissue binding characteristics, necessitating a higher dose to achieve therapeutic serum concentrations. * **Renal Clearance:** Once the neonatal period passes, renal clearance of Digoxin is relatively efficient in children. **2. Analysis of Options:** * **Option A (0.02-0.04) & B (0.03-0.05):** These ranges are generally too low for the standard pediatric maintenance dose and may result in sub-therapeutic levels, though 0.02-0.03 mg/kg is sometimes considered for preterm neonates who have immature renal function. * **Option D (0.06-0.08):** This range approaches toxic levels. Digoxin has a narrow therapeutic index; doses in this range significantly increase the risk of arrhythmias and gastrointestinal toxicity. **3. High-Yield Clinical Pearls for NEET-PG:** * **Loading Dose:** The Total Digitalizing Dose (TDD) is usually divided into three doses (50% initially, then 25% and 25% at 8-hour intervals). * **Monitoring:** Always monitor serum potassium; **hypokalemia** predisposes the patient to digoxin toxicity because potassium and digoxin compete for the same binding site on the $Na^+/K^+$-ATPase pump. * **Antidote:** Digoxin-specific Fab fragments (Digibind) is the treatment of choice for life-threatening toxicity. * **ECG Change:** The most common initial sign of toxicity in children is often **bradycardia** or AV block, rather than the visual disturbances seen in adults.

Q: Which electrolyte imbalance is commonly caused by carbamazepine in elderly patients?

Hyponatremia. **Explanation:** **Carbamazepine** is a well-known cause of **Hyponatremia** (Option B), particularly in the elderly. This occurs through a mechanism known as **SIADH (Syndrome of Inappropriate Antidiuretic Hormone secretion)** or a "vasopressin-like" effect [1]. Carbamazepine increases the sensitivity of the renal collecting duct receptors to ADH and stimulates the release of endogenous ADH [2]. This leads to excessive water reabsorption, resulting in dilutional hyponatremia. Elderly patients are at higher risk due to age-related changes in water homeostasis and the frequent concomitant use of other drugs like diuretics or SSRIs. **Analysis of Incorrect Options:** * **Hypernatremia (A):** Carbamazepine causes water retention, not water loss or sodium gain; therefore, it does not cause hypernatremia. * **Hyperkalemia (C) & Hypokalemia (D):** While carbamazepine primarily affects sodium channels and ADH activity, it does not have a direct or clinically significant effect on potassium levels. Potassium imbalances are more commonly associated with diuretics, ACE inhibitors, or mineralocorticoids. **High-Yield Clinical Pearls for NEET-PG:** * **Oxcarbazepine:** A prodrug of carbamazepine, it is actually associated with a *higher* incidence of hyponatremia than carbamazepine itself. * **Monitoring:** Baseline and periodic serum sodium levels should be monitored in elderly patients starting carbamazepine. * **Other Side Effects:** Remember the "3 Ds" for Carbamazepine: **D**iplopia, **D**izziness, and **D**rowsiness. It is also a potent **Cytochrome P450 enzyme inducer** and can cause **Stevens-Johnson Syndrome** (especially in patients with the HLA-B*1502 allele).

Q: Most common cause of Mobius syndrome is the use of which of the following drugs in pregnancy?

Misoprostol. **Explanation:** **1. Why Misoprostol is the Correct Answer:** Misoprostol is a synthetic prostaglandin E1 (PGE1) analog frequently used off-label as an abortifacient. When used in the first trimester for failed medical abortion, it can cause **vascular disruption** in the developing fetus. The leading theory is that misoprostol-induced uterine contractions lead to transient uterine ischemia, affecting the development of the cranial nerve nuclei (specifically the 6th and 7th nerves). This results in **Mobius Syndrome**, characterized by congenital facial paralysis and impaired ocular abduction (mask-like facies). **2. Why Other Options are Incorrect:** * **Thalidomide:** Classically associated with **Phocomelia** (seal-like limbs), amelia, and internal organ defects. While it can cause ear and eye abnormalities, it is not the primary cause of Mobius syndrome. * **Methotrexate:** A folic acid antagonist that causes **Fetal Hydantoin-like syndrome** or "Methotrexate embryopathy," characterized by skull defects (craniosynostosis), limb malformations, and growth retardation. * **Dinoprostone:** A PGE2 analog used for cervical ripening at term. It is not typically associated with first-trimester teratogenicity or Mobius syndrome, as it is not commonly used for early medical abortions. **3. High-Yield Clinical Pearls for NEET-PG:** * **Mobius Syndrome Triad:** Facial nerve palsy (CN VII), Abducens nerve palsy (CN VI), and often limb defects (e.g., clubfoot). * **Misoprostol Teratogenicity:** Apart from Mobius syndrome, it is also linked to **Terminal Transverse Limb Defects**. * **Safe Alternatives:** For labor induction, Dinoprostone is preferred; for postpartum hemorrhage (PPH), Misoprostol is a key drug. * **Other Vascular Disruptors:** Cocaine and Ergotamine are also associated with vascular-mediated fetal defects.

Q: A woman treated with lithium during pregnancy, the fetus should be tested for which of the following?

Cardiac malformations. **Explanation:** Lithium is a well-known teratogen, and its use during the first trimester of pregnancy is specifically associated with an increased risk of **cardiac malformations**. The most characteristic defect is **Ebstein’s Anomaly**, which involves the apical displacement of the tricuspid valve leaflets, leading to "atrialization" of the right ventricle and severe tricuspid regurgitation. While the absolute risk is lower than previously thought (approx. 1-2 per 1000), it remains significantly higher than the general population. **Analysis of Incorrect Options:** * **Neural Tube Defects (NTDs):** These are primarily associated with **Valproate** and **Carbamazepine** due to interference with folate metabolism. * **Urogenital Abnormalities:** These are not typically associated with Lithium. Examples include hypospadias, which can be seen with certain anti-androgens or environmental factors. * **Scalp Defects (Aplasia Cutis Congenita):** This is a classic side effect associated with the use of **Methimazole** (anti-thyroid drug) during the first trimester. **High-Yield Clinical Pearls for NEET-PG:** * **Ebstein’s Anomaly:** Look for "atrialization of the right ventricle" in the question stem. * **Lithium in Pregnancy:** If used near term, it can cause **"Floppy Infant Syndrome"** (cyanosis, hypotonia, and poor suckling). * **Monitoring:** Fetal echocardiography is recommended at 18–20 weeks of gestation for mothers taking Lithium. * **Breastfeeding:** Lithium is generally avoided during breastfeeding as it is excreted in milk and can cause neonatal toxicity.

Q: Which of the following NSAIDs has been approved for use in children?

Ibuprofen. **Explanation:** **Correct Answer: B. Ibuprofen** **Medical Concept:** Pediatric pharmacotherapy requires drugs with a high safety profile and well-established dosing guidelines. **Ibuprofen** is one of the most commonly used and safest NSAIDs in children. It is FDA-approved for use in infants as young as **6 months** for its analgesic, anti-inflammatory, and antipyretic properties. It works by reversibly inhibiting COX-1 and COX-2 enzymes. Along with Paracetamol, it is a first-line agent for managing pediatric fever and pain. **Analysis of Incorrect Options:** * **A. Indomethacin:** While used in neonates specifically for the medical closure of **Patent Ductus Arteriosus (PDA)**, it is generally avoided as a routine analgesic/antipyretic in children due to its high incidence of systemic side effects (GI bleed, renal toxicity). * **C. Ketorolac:** This is a potent NSAID primarily used for short-term management of severe post-operative pain. It is generally not recommended for routine use in children under 16 years (or strictly limited to inpatient settings) due to the high risk of gastrointestinal bleeding and renal impairment. * **D. Piroxicam:** This oxicam derivative has a very long half-life (~50 hours), making it difficult to manage in pediatric populations where metabolic rates vary. It is associated with a higher risk of serious skin reactions (Stevens-Johnson Syndrome). **High-Yield NEET-PG Pearls:** * **Aspirin Warning:** Never use Aspirin in children with viral infections (Flu, Chickenpox) due to the risk of **Reye’s Syndrome** (fulminant hepatic failure and encephalopathy). * **Drug of Choice for PDA:** Intravenous **Indomethacin** or **Ibuprofen** (Ibuprofen is often preferred now due to less renal vasoconstriction). * **Safe Age:** Ibuprofen is typically started after 6 months; Paracetamol (Acetaminophen) can be used from birth.

Q: Which drug may lead to hemolysis in a child with G6PD deficiency?

Primaquine. **Explanation:** **1. Why Primaquine is Correct:** Glucose-6-Phosphate Dehydrogenase (G6PD) is a critical enzyme in the pentose phosphate pathway that maintains the levels of **reduced glutathione** in red blood cells. Reduced glutathione acts as an antioxidant, protecting RBCs from oxidative stress. **Primaquine**, an antimalarial used for the radical cure of *P. vivax* and *P. ovale*, is a potent oxidizing agent. In G6PD-deficient individuals, the inability to regenerate glutathione leads to the oxidation of hemoglobin, forming **Heinz bodies**, which results in acute hemolysis and hemoglobinuria. **2. Why Other Options are Incorrect:** * **Penicillin & Ceftriaxone (Beta-lactams):** These drugs are generally safe in G6PD deficiency. While they can occasionally cause immune-mediated hemolytic anemia (Type II hypersensitivity), they do not cause oxidative hemolysis. * **Erythromycin (Macrolide):** This antibiotic is not associated with oxidative stress or hemolysis in G6PD-deficient patients. **3. High-Yield Clinical Pearls for NEET-PG:** * **Other common triggers:** Sulfonamides (Dapsone, Cotrimoxazole), Nitrofurantoin, Nalidixic acid, and Fava beans (Favism). * **Diagnosis:** Peripheral smear shows **"Bite cells"** (degmacytes) and **Heinz bodies** (denatured hemoglobin visible with supravital stains like Crystal Violet). * **Inheritance:** G6PD deficiency is an **X-linked recessive** disorder, making it more common in males. * **Screening:** Always screen for G6PD deficiency before initiating Primaquine or Dapsone therapy.

Q: What is the most important factor for calculating the dose of NSAIDs in children?

Body weight of the child. **Explanation:** The correct answer is **B. Body weight of the child.** In pediatric pharmacology, the most reliable and standard method for calculating drug dosages, including NSAIDs (like Ibuprofen or Paracetamol), is based on **body weight (mg/kg)**. This is because children are not merely "small adults"; their physiological processes—including volume of distribution, metabolic rate, and renal clearance—correlate more closely with body mass than chronological age. Using weight ensures that the plasma concentration of the drug remains within the therapeutic window, minimizing the risk of toxicity or sub-therapeutic dosing. **Analysis of Incorrect Options:** * **A. Age of the child:** While age-based rules (e.g., Young’s Rule) exist, they are often inaccurate because children of the same age can have vastly different weights. Age is a poor predictor of metabolic maturity in older children. * **C. Flavor of the salt:** Flavor affects **compliance** (palatability), especially in liquid formulations, but it has no bearing on the pharmacological dose calculation. * **D. Extent of pain:** While the severity of pain may dictate the *choice* of analgesic (e.g., NSAID vs. Opioid), the specific dose of a chosen NSAID must still be calculated based on weight to ensure safety. **High-Yield Clinical Pearls for NEET-PG:** * **Body Surface Area (BSA):** While weight is the most common method, **BSA** is considered the *most accurate* method for calculating doses (especially for chemotherapy), as it correlates better with cardiac output and glomerular filtration rate. * **Aspirin Caution:** Never use Aspirin in children with viral infections (like Flu or Varicella) due to the risk of **Reye’s Syndrome**. * **Ibuprofen Dose:** The standard pediatric dose is **5–10 mg/kg** every 6–8 hours. * **Paracetamol Dose:** The standard pediatric dose is **10–15 mg/kg** every 4–6 hours.

Q: Which of the following drugs should be avoided in a 7-year-old child?

Ofloxacin. **Explanation:** **Correct Option: C (Ofloxacin)** Ofloxacin belongs to the **Fluoroquinolone** class of antibiotics. In pediatric patients (typically those under 18 years of age), fluoroquinolones are generally avoided because they can cause **arthropathy and permanent cartilage damage** in weight-bearing joints. Studies in juvenile animals demonstrated that these drugs lead to the erosion of cartilage, which has led to a cautious approach in human clinical practice. While they are used in specific life-threatening conditions (e.g., complicated UTIs or cystic fibrosis exacerbations), they are contraindicated for routine use in a 7-year-old. **Incorrect Options:** * **A & D (Cefixime and Amoxicillin):** These are Beta-lactam antibiotics (Cephalosporin and Penicillin, respectively). They are considered the first-line, safest, and most commonly prescribed antibiotics in pediatrics for various infections. * **B (Erythromycin):** This is a Macrolide antibiotic. While it can cause GI upset or, rarely, hypertrophic pyloric stenosis in neonates, it is generally safe and frequently used in older children (like a 7-year-old) for respiratory infections. **High-Yield Clinical Pearls for NEET-PG:** * **Tetracyclines:** Avoided in children <8 years due to **permanent tooth discoloration** and bone growth retardation. * **Chloramphenicol:** Avoided in neonates due to **Gray Baby Syndrome** (caused by deficient glucuronide conjugation). * **Sulfonamides:** Avoided in newborns as they displace bilirubin from albumin, leading to **Kernicterus**. * **Promethazine:** Contraindicated in children <2 years due to the risk of fatal **respiratory depression**.

Q: Which of the following drugs is NOT contraindicated in pregnancy?

Chloroquine. **Explanation:** The correct answer is **Chloroquine**. In pharmacological management during pregnancy, drugs are categorized based on their teratogenic potential. Chloroquine is considered safe for both the prophylaxis and treatment of malaria in pregnant women across all trimesters. **Why Chloroquine is Correct:** Chloroquine does not have documented teratogenic effects at standard antimalarial doses. Since malaria itself poses a significant risk to both the mother (anemia, hypoglycemia) and the fetus (IUGR, stillbirth), Chloroquine remains the drug of choice where sensitivity exists. **Why the Other Options are Incorrect:** * **Primaquine:** It is strictly contraindicated in pregnancy. It can cross the placenta and cause **severe hemolysis** in the fetus, especially if the fetus has an undetected G6PD deficiency. * **Tobramycin:** As an Aminoglycoside, it is associated with **ototoxicity** (damage to the 8th cranial nerve) in the fetus, potentially leading to congenital deafness. * **ACE Inhibitors (e.g., Enalapril):** These are potent teratogens, particularly in the 2nd and 3rd trimesters. They cause **fetal renal dysgenesis**, oligohydramnios, skull hypoplasia, and intrauterine growth restriction (IUGR). **High-Yield Clinical Pearls for NEET-PG:** * **Safe Antimalarials:** Chloroquine, Quinine, and Clindamycin are generally safe. * **Safe Antihypertensives:** Labetalol (Drug of choice), Methyldopa, and Hydralazine. * **Teratogenic Mnemonic (TERATO):** **T**halidomide (Phocomelia), **E**pileptic drugs (Valproate - Neural tube defects), **R**etinoids (Craniofacial defects), **A**CE inhibitors (Renal damage), **T**etracyclines (Discolored teeth), **O**ther (Warfarin - Fetal Warfarin Syndrome).

Question 1

What is the maintenance dose of digoxin in a child, expressed in mg/kg?

Accepted Answer

0.04-0.06

Answer

0.02-0.04

Answer

0.03-0.05

Answer

0.06-0.08

Question 2

Which electrolyte imbalance is commonly caused by carbamazepine in elderly patients?

Accepted Answer

Hyponatremia

Answer

Hypernatremia

Answer

Hyperkalemia

Answer

Hypokalemia

Question 3

Most common cause of Mobius syndrome is the use of which of the following drugs in pregnancy?

Accepted Answer

Misoprostol

Answer

Thalidomide

Answer

Methotrexate

Answer

Dinoprostone

Question 4

A woman treated with lithium during pregnancy, the fetus should be tested for which of the following?

Accepted Answer

Cardiac malformations

Answer

Neural tube defects

Answer

Urogenital abnormalities

Answer

Scalp defects

Question 5

Which of the following NSAIDs has been approved for use in children?

Accepted Answer

Ibuprofen

Answer

Indomethacin

Answer

Ketorolac

Answer

Piroxicam

Question 6

Which pharmacokinetic change commonly occurs in geriatric patients?

Accepted Answer

Renal clearance

Answer

Gastric absorption

Answer

Liver metabolism

Answer

Hypersensitivity

Question 7

Which drug may lead to hemolysis in a child with G6PD deficiency?

Accepted Answer

Primaquine

Answer

Penicillin

Answer

Ceftriaxone

Answer

Erythromycin

Question 8

What is the most important factor for calculating the dose of NSAIDs in children?

Accepted Answer

Body weight of the child

Answer

Age of the child

Answer

Flavor of the salt

Answer

Extent of pain

Question 9

Which of the following drugs should be avoided in a 7-year-old child?

Accepted Answer

Ofloxacin

Answer

Cefixime

Answer

Erythromycin

Answer

Amoxicillin

Question 10

Which of the following drugs is NOT contraindicated in pregnancy?

Accepted Answer

Chloroquine

Answer

Primaquine

Answer

Tobramycin

Answer

ACE inhibitor

Pediatric and Geriatric Pharmacology — MCQs

Pediatric and Geriatric Pharmacology — MCQs

On this page

Practice by Chapter

Want unlimited practice?